Correction: Delivery of therapeutics targeting the mRNA-binding protein HuR using 3DNA nanocarriers suppresses ovarian tumor growth

Abstract

In this article (Cancer Res 2016;76:1549-59), which appeared in the March 15, 2016 issue of Cancer Research (1), an affiliation was not listed for Janet A. Sawicki. Dr. Sawicki's correct affiliations are as follows: Lankenau Institute for Medical Research, Wynnewood, Pennsylvania. Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania. Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.